Endovascular treatment of abdominal aorta aneurysms with hostile anatomy: the reality and the dream by Alves, Claudia Maria Rodrigues
Endovascular Treatment of Abdominal  
Aorta Aneurysms with Hostile Anatomy  
– The Reality and the Dream
Claudia Maria Rodrigues Alves
Editorial
Rev Bras Cardiol Invasiva. 
2012;20(1):13-5
Escola Paulista de Medicina – Universidade Federal de São Paulo (Unifesp) – São Paulo, SP, Brazil.
Correspondence to: Claudia Maria Rodrigues Alves. Rua Simão Álvares, 527/63 – Pinheiros – São Paulo, SP, Brazil – CEP 05417-030. 
E-mail: cmralves@uol.com.br
Received on: 3/7/2012 • Accepted on: 3/8/2012
T he rapid dissemination of endovascular treatment for abdominal aorta aneurysms was a conse-quence of the excellent, immediate results of the 
procedure, which caused it to quickly surpass open 
surgery.1 In properly selected patients, endovascular 
treatment can reduce the risk of death and compli-
cations in the acute phase compared with surgical 
treatment, although long-term mortality is similar 
for both procedures.2,3 The clinical effectiveness of 
endovascular treatment is undeniable, as shown by 
the extremely high five-year survival rate and by the 
low incidence of late disruption.
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The high percentage of elderly patients with advanced 
atherosclerotic disease and frequent comorbidities who 
presented high surgical risk was also a strong stimulus 
for the quick acceptance of endovascular treatment. 
Although patients who are not candidates for surgery 
also present a high mortality rate within 30 days after 
endovascular treatment,4 age is a relatively unimport-
ant factor, and there are data indicating good results 
for even very elderly patients who have undergone 
endovascular treatment.5
Despite a high rate of technical success in select 
cases, anatomical limitations in patient selection were 
quickly recognised and challenged. Although endo-
vascular treatment was developed to eliminate lesions 
from the connections among normal portions of the 
vessel along the proximal and distal route to the an-
eurysm, the strategy was extended to a large number 
of patients presenting unfavourable anatomy. The major 
point of vulnerability is in the neck of the prosthesis 
landing, due to augmented diameter, short exten sion 
or unfavourable angulation. The frequency of hostile 
anatomy in this patient population can be as high as 
50% to 60%.6,7
In this issue of the Revista Brasileira de Cardiolo-
gia Invasiva, Metzger et al.8 reported their experience 
treating a small group of patients with hostile anatomy, 
defined by the presence of a strong angulation in the 
proximal aortic neck or in the emergence of the iliac 
arteries. In the authors’ experience, the use of a de-
vice whose characteristics were ideal for this situation 
produced acceptable success and complication rates. 
In order to put these data into perspective, the results 
are summarized here.
In initial studies to evaluate endovascular treat-
ment of abdominal aorta aneurysms, the unfavourable 
anatomical characteristics included angulation of the 
proximal neck > 30 degrees, neck extension < 15 mm, 
and conical morphology and neck diameter > 28 mm. For 
the distal neck, unfavourable anatomical characteristics 
included angulation in the iliacs > 90 degrees, diameter 
> 18 mm or < 6 mm and, finally, the presence of a 
stenotic lesion > 50%.9 Presently, most manufactur-
ers of devices designed for endovascular treatment of 
abdominal aorta aneurysms recommend a proximal 
neck angle < 60 degrees and at least 10 mm long 
(for suprarenal fixation) as a criterion of anatomical 
indication, reflecting a great advance in such devices.
Traditionally, for endovascular procedures in general, 
hostile anatomy is a risk factor for reduced success, 
complications, and death. In the case of aortic disease, 
hostile anatomy also carries an additional late risk in 
the form of a greater incidence of leaks. The avail-
ability of several devices has allowed for the treatment 
with multiple unfavourable characteristics by means 
of several “tricks” in the development of prostheses. 
Literature related to the AnacondaTM (Vascutek, Terumo, 
Inchinnan, Scotland) device is still limited and does 
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not specifically identify patients with high anatomical 
risk, who usually account for a small percentage of the 
total patient population.10,11 An analysis of patients with 
a minimal extension of 15 mm in the proximal neck 
included 787 patients, and a series of 100 patients 
showed equivalent results for patients with ideal and 
hostile anatomies.
The most modern devices have allowed for the 
treatment of anatomically diverse patients with success 
and complication rates that are equivalent to those 
of well-selected cases. However, patients with hostile 
anatomy have a greater need for auxiliary procedures 
(intra- or postoperative), especially for the resolution of 
Type I endoleaks detected in the index procedure.7,12 
These auxiliary procedures increase costs and morbidity 
rates. Furthermore, enlargement of the aneurysmatic sac 
is very often observed as a later development.7 In an 
analysis of a large database of images of endovascular 
treatment for abdominal aorta aneurysms, comprising 
over 10,000 patients treated between 1999 and 2008, 
the frequency of patients with major angulations and 
conical necks progressed throughout the years. The 
rates of diameter increase in the abdominal aorta 
aneurysm were significantly higher after 3 years of 
follow-up in patients treated under a liberal anatomi-
cal criterion, when compared with those who met a 
restricted anatomical criterion. A proximal neck diameter 
> 32 mm (hazard ratio [HR] 2.07, 95% confidence inter-
val [95% CI] 1.46-2.92) and aortic angle > 60 degrees 
(HR 1.96, CI 95% 1.63–2.37) predicted a subsequent 
increase in the diameter.7 Although the image reviews 
in this retrospective and limited analysis do not reflect 
the rates usually reported for diameter increase of the 
aneurysmatic sac (40% versus approximately 10% in a 
period of three to five years) or the clinical significance 
of this finding, they represent a good example of the 
differences in results arising from liberal patient selection.
The good results that were previously obtained 
in the treatment of patients with moderate to severe 
angles in their aortic neck are most likely a result of 
highly experienced teams and the use of a specific 
device.7,13 It is important to stress that the excellent 
mortality/morbidity data associated with endovascular 
treatment compared with open surgery apply to patients 
with adequate anatomy, and the chance of late events 
related to inadequate selection is significantly higher 
among patients with a hostile anatomy than among ideal 
cases.14 Extrapolating this comparison to the larger group 
of patients who present hostile anatomy is inadequate, 
even though the initial results are encouraging.
The generalisation of these data is also difficult 
in patients with multiple clinical and anatomical risk 
factors. For this reason, many consider treatment indi-
vidualisation to be a reasonable strategy. The introduc-
tion of fenestrated and ramified devices has advanced 
the possibility of anatomical treatment for nearly every 
patient, regardless of anatomy. Careful consideration of 
the cost-effectiveness of this very expensive procedure, 
especially in the public health system, deserves ad-
ditional attention.
It is important to note that the treatment of complex 
cases demands training and experience that cannot 
easily be obtained with a low number of cases. These 
patients must be treated in major reference centres, 
ideally with the possibility of providing different types 
of prostheses and complementing the treatment using 
a percuta neous route when needed, as described by 
Metzger et al.8 It is also necessary to inform patients of 
the higher frequency of late leaks and the importance of 
constant supervision. Acceptable thresholds of success 
and complications when wider anatomical indication 
criteria are applied have yet to be defined.
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